The differential susceptibility of specific neuronal populations: Insights from Huntington's disease

IUBMB Life

Volumn 55, Issue 6, 2003, Pages 293-298

  Mitchell, Ian J ^a   Griffiths, Mark R ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Caspase; Free radicals; Huntington's; Parkinson's; Reactive oxygen species; Striatum; Trophic factors

Indexed keywords

CALCIUM BINDING PROTEIN; CASPASE; MUTANT PROTEIN; REACTIVE OXYGEN METABOLITE; SCAVENGER;

CALCIUM CELL LEVEL; DISEASE PREDISPOSITION; ENZYME ACTIVITY; GENE EXPRESSION; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; NERVE CELL; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; PATHOGENESIS; PROTEIN INTERACTION; REVIEW;

CELL DEATH; DISEASE SUSCEPTIBILITY; GENE EXPRESSION REGULATION; HUMANS; HUNTINGTON DISEASE; MUTATION; NERVE DEGENERATION; NEURONS;

LETHRINIDAE;

EID: 0041526737     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/1521654031000153012     Document Type: Review

References (29)

1. Mitchell, I. J., Cross, A. J., Sambrook, M. A., and Crossman, A. R. (1985) Sites of the neurotoxic action of 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus. Neurosci. Lett. 61, 195-200.
2. West, M. J., Kawas, C. H., Martin, L. J., and Troncoso, J. C. (2000) The CA1 region of the human hippocampus is a hot spot in Alzheimer's disease. Ann. N.Y. Acad. Sci. 908, 255-259.
3. Albin, R. L., and Tagle, D. A. (1995) Genetics and molecular biology of Huntington's disease. TINS. 18, 11-14.
4. Walling, H. W., Baldassare, J. J., and Westfall, T. C. (1998) Molecular aspects of Huntington's disease. J. Neurosci. Res. 54, 301-308.
5. Ferrante, R. J., Gutekunst, C. A., Persichetti, F., McNeil, S. M., Kowall, N. W., Gusella, J. F., MacDonald, M. E., Beal, M. F., and Hersch, S. M. (1997) Heterogeneous topographic and cellular distribution of Huntingtin expression in the normal human neostriatum. J. Neurosci. 17, 3052-3063.
6. Duyao, M., Ambrose, C., Myers, R., Novelletto, A., Persichetti, F., Frontali, M., Folstein, S., Ross, C., Franz, M., Abbott, M., et al. (1993) Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat. Genet. 4, 387-392.
7. Diamond, M. I., Robinson, M. R., and Yamamoto, K. R. (2000) Regulation of expanded polyglutamine protein aggregation and nuclear localization by the glucocorticoid receptor. Proc. Natl. Acad. Sci. 97, 657-661.
8. Fusco, F. R., Chen, Q., Lamoreaux, W. J., Figueredo-Cardenas, G., Jiao, Y., Coffman, J. A., Surmeier, D. J., Honig, M. G., Carlock, L. R., and Reiner, A. (1999) Cellular localization of Huntingtin in striatal and cortical neurons in rats: Lack of correlation with neuronal vulnerability in Huntington's disease. J. Neurosci. 19, 1189-1202.
9. Vonsattel, J.-P. G., and DiFiglia, M. (1998) Huntington Disease. J. Neuropathol. Exp. Neurol. 57, 369-384.
10. Albin, R. L., Reiner, A., Anderson, K. D., Leon, S., Dure, I. V., Handelin, B., Balfour, R., Whetsell, W. O., Penney, J. B., and Young, A. B. (1992) Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease. Ann. Neurol. 31, 425-430.
11. Hedreen, J. C., and Folstein, S. E. (1995) Early loss of neostriatal striosome neurons in Huntington's disease. J. Neuropath. Exp. Neurol. 54, 105-120.
12. Nishino, H., Hida, H., Kumazaki, M., Shimano, Y., Nakajima, K., Shimizu, H., Ooiwa, T., and Baba, H. (2000) The striatum is the most vulnerable region in the brain to mitochondrial energy compromise: A hypothesis to explain its specific vulnerability. J. Neurotrauma 17, 251-260.
13. Gasque, P., Dean, Y. D., McGreal, E. P., VanBeek, J., and Morgan, B. P. (2000) Complement components of the innate immune system in health and disease in the CNS. Immunopharmacology 49, 171-186.
14. Portera-Cailliau, C., Hedreen, J. C., Price, D. L., and Koliatsos, V. E. (1995) Evidence for apoptotic cell death in Huntington's disease and excitotoxic animal models. J. Neurosci. 15, 3775-3787.
15. Cattaneo, E., Rigamonti, D., and Zuccato, C. (2002) The enigma of Huntington's disease. Scientific American 287, 92-97.
16. Gervais, F. G., Singaraja, R., Xanthoudakis, S., Gutekunst, C. A., Leavitt, B. R., Metzler, M., Hackam, A. S., Tam, J., Vaillancourt, J. P., Houtzager, V., et al. (2002) Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi. Nat. Cell Biol. 4, 95-105.
17. Nasir, J., Goldberg, Y. P., and Hayden, M. R. (1996) Huntington disease: new insights into the relationship between CAG expansion and disease. Human Mol. Genet. 5, 1431-1435.
18. 2+] increase and cell damage in cultured rat cerebral endothelia cells. Brain Res. 956, 116-125.
19. Galpern, W. R., Matthews, R. T., Beal, M. F., and Isacson, O. (1996) NGF attenuates 3-nitrotyrosine formation in a 3-NP model of Huntington's disease. Neuroreport 7, 2639-2642.
20. Cassarino, D. S., and Bennett, J. P. (1999) An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration. Brain Res. Rev. 29, 1-25.
21. Reynolds, D. S., Carter, R. J., and Morton, A. J. (1998) Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease. J. Neurosci. 18, 10116-10127.
22. Page, K. J., Petter, L., Aronni, S., Everitt, B. J., and Dunnett, S. B. (1998) The expression of Huntingtin-associated protein (HAP-1) mRNA in developing, adult and ageing rat CNS: implications for Huntington's disease neuropathology. Eur. J. Neurosci. 10, 1835-1845.
23. Jiang, X., Kim, H. E., Shu, H., Zhao, Y., Zhang, H., Kofron, J., Donnelly, J., Burns, D., Ng, S. C., Rosenberg, S., and Wang, X. (2003) Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science 262 (5604), 223-226.
24. Kobayashi, Y., Kume, A., Li, M., Doyu, M., Hata, M., Ohtsuka, K., and Sobue, G. (2000) Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expanded polyglutamine tract. J. Biol. Chem. 275, 8772-8778.
25. Brouillet, E., Conde, F., Beal, M. F., and Hantraye, P. (1999) Replicating Huntington's disease phenotype in experimental animals. Prog. Neurobiol. 59, 427-468.
26. + ATPase. Eur. J. Neurosci. 7, 1674-1683.
27. Mitchell, I. J., Cooper, A. J., and Griffiths, M. R. (1999) Selective vulnerability of striatopallidal neurons. Prog. Neurobiol. 59, 691-719.
28. Behl, C. (2000) Vitamin E protects against oxidative cell death in vitro more effectively than 17-beta estradiol and induces the activity of the transcription factor NF-kappa B. J. Neural Transm. 107, 393-407.
29. Haynes, L. E., Lendon, C. L., Barber, D. J., and Mitchell, I. J. (2003) 17-beta-estradiol attenuates dexamethasone induced lethal and sublethal neuronal damage in the striatum and hippocampus. Neuroscience (In press).